As the preclinical systematic review study found, KXS, most treated for Alzheimer's Disease and Depression, has an effect on antioxidant activity by decreased ROS and MDA levels via increased GSH and SOD levels. The gene discussed is SOD1; the disease is early-onset autosomal dominant Alzheimer disease.